No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR

References

• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001; 344: 1688–1700
   PubMed Web of Science ®Google Scholar
• Hoffman PM, Festoff BW, Giron LT, Jr, Hollenbeck LC, Garruto RM, Ruscetti FW. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med. 1985; 313: 324–3
   PubMed Web of Science ®Google Scholar
• Verma RK, Ziegler DK, Kepes JJ. HIV-related neuromuscular syndrome simulating motor neuron disease. Neurology. 1990; 40: 544–6
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. Journal of Neurological Sciences. 1991; 106: 199–205
   PubMed Web of Science ®Google Scholar
• King EW. Does a retrovirus cause amyotrophic lateral sclerosis?. Annals of Neurology. 1991; 30: 431–3
   PubMed Web of Science ®Google Scholar
• Jubelt B. Motor neuron disease and viruses: poliovirus, retroviruses, and lymphomas. Current Opinion in Neurology and Neurosurgery. 1992; 5: 655–8
   PubMedGoogle Scholar
• Westarp ME, Bartmann P, Rossle J, Geiger E, Westphal K-P, Schreiber H, et al. Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Neuroreport. 1993; 4: 819–22
   PubMed Web of Science ®Google Scholar
• Huang PP, Chin R, Song S, Lasoff S. Lower motor neuron dysfunction associated with human immunodeficiency virus infection. Arch Neurol. 1993; 50: 1328–30
   PubMedGoogle Scholar
• Ferrante P, Westarp ME, Mancuso R, Puricelli S, Westarp MP, Mini M. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 1995; 129: 140–4
   PubMed Web of Science ®Google Scholar
• Westarp ME, Ferrante P, Perron H, Bartmann P, Kornhuber HH. Sporadic ALS/MND: a global nuerodegeneration with retroviral involvement?. J Neurol Sci. 1995; 129: 145–7
   PubMed Web of Science ®Google Scholar
• Love S. The search for a transmissible agent in ALS. Brain Pathol. 1996; 6: 99–100
   PubMed Web of Science ®Google Scholar
• Galassi G, Gentilini M, Ferrari S, Ficarra G, Zonari P, Mongiardo N, et al. Motor neuron disease and HIV-1 infection in a 30-year-old HIV-positive heroin abuser; a causal relationship?. Clin Neuropathol. 1998; 17: 131–5
   PubMed Web of Science ®Google Scholar
• Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuju K, Higuchi I, et al. HTLV-I-associated myelopathy (HAM)/tropical spastic pararesis (TSP) with amyotrophic lateral sclerosis-like manifestations. Journal of NeuroVirology. 2000; 6: 544–8
   PubMed Web of Science ®Google Scholar
• Sastre-Garriga J, Tintore M, Raguer N, Ruiz I, Montalban X, Codina A. Lower motor neuron disease in a HIV-2 infected woman. J Neurol. 2000; 247: 718–9
   PubMed Web of Science ®Google Scholar
• Moulignier A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology. 2001; 57: 995–1001
   PubMed Web of Science ®Google Scholar
• MacGowan DJL, Scelsa SN, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001; 57: 1094–7
   PubMed Web of Science ®Google Scholar
• Von Geisen HJ, Kaiser R, Koller H, Wetzel K, Arendt G. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2002; 59: 474
   Google Scholar
• Pearl D, Noursadeghi M, Manji H, Edwards S, Miller R. Lower motor neuron syndrome and HIV infection. Sex Transm Infect. 2002; 79: 351
   Web of Science ®Google Scholar
• Zoccolella S, Carbonara S, Minerva D, Palagano G, Bruno F, Ferrannini E, et al. A case of concomitant amyotrophic lateral sclerosis and HIV infection. Eur J Neurol. 2002; 9: 180–2
   PubMed Web of Science ®Google Scholar
• Sinha S, Mathews T, Arunodaya GR, Siddappa NB, Ranga U, Desai A, clade-C-associated HIV-1, et al. ‘ALS’-like disorder: first report from India. J Neurol Sci. 2004; 224: 97–100
   PubMed Web of Science ®Google Scholar
• Silva MTT, Leite ACC, Alamy AH, Chimelli L, Andrada-Serpa MJ, Araujo AQC. ALS syndrome in HTLV-I infection. Neurology. 2005; 65: 1332–3
   PubMed Web of Science ®Google Scholar
• Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. Journal of the Neurological Sciences. 2006; 240: 59–64
   PubMed Web of Science ®Google Scholar
• Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, et al. Detection of reverse transcriptase activity in the serum of patients with motor neuron disease. Journal of Medical Virology. 2000; 61: 527–32
   PubMed Web of Science ®Google Scholar
• Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RHJr, Garson JA. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005; 64: 454–8
   PubMed Web of Science ®Google Scholar
• MacGowan DJL, Scelsa SN, Imperato TE, Liu K-N, Baron P, Polsky B. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology. 2007; 68: 1944–6
   PubMed Web of Science ®Google Scholar
• McCormick AL, Brown RH, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008; 70: 278–83
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314: 130–3
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotempoaral lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351: 602–11
   PubMed Web of Science ®Google Scholar
• Hynd MR, Lewohl JM, Scott HL, Dodd PR. Biochemical and molecular studies using human autopsy brain tissue. Journal of Neurochemistry. 2003; 85: 543–62
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. American Journal of Pathology. 2002; 161: 1961–71
   PubMed Web of Science ®Google Scholar
• Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007; 68: 1576–82
   PubMed Web of Science ®Google Scholar
• Schroeder, A, Mueller, O, Stocker, S, Salowsky, R, Leiber, M, Gassmann, M, , et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Molecular Biology, 2006. Jan 31;7:3.
   PubMed Web of Science ®Google Scholar
• Ma H. Development application of polymerase chain reaction (PCR). The Journal of American Science. 2005; 1: 1–47
   Google Scholar
• Gendelman, HE, Grant, I, Everall, IP, Lipton, SA, Swindells, S. The Neurology of AIDS 2nd edn. Oxford University Press. 2005; 19–20.
   Google Scholar
• Dickson DW, Mattiace LA, Jure K, Hutchins K, Lyman WD, Brosnan CF. Microglia in human disease, with an emphasis on acquired immune deficiency syndromes. Lab Invest. 1991; 64: 135–56
   PubMed Web of Science ®Google Scholar
• Boven LA. Macrophages and HIV-1-associated dementia. Archivum Immunologiae et Therapiae Experimentalis. 2000; 48: 273–9
   PubMedGoogle Scholar
• Langford D, Masliah E. Cross-talk between components of the blood-brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathology. 2001; 11: 306–12
   PubMed Web of Science ®Google Scholar
• Scicchitano MS, Dalmas DA, Bertiaus MA, Anderson SM, Turner LR, Thomas RA, et al. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. Journal of Histochemistry and Cytochemistry. 2006; 54: 1229–37
   PubMed Web of Science ®Google Scholar
• Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol. 1995; 40: 249–59
   PubMed Web of Science ®Google Scholar
• Cronelissen M, van den Burg R, Zorgdrager F, Lukashov V, Goudsmit J. Pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occuring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. Journal of Virology. 1997; 71: 6348–58
   PubMed Web of Science ®Google Scholar